Meet the Expert: Robert Beall, PMP

December 22, 2020

ProPharma Group has launched a “Meet the Expert” series introducing you to our experts from around the world. This series will help you get to know who we are, and how our colleagues work to improve patient health and safety throughout the complete product lifecycle.

Meet the Expert: Robert Beall, PMP, Vice President, Key Accounts

Can you tell us what you do?

As the Vice President of Key Accounts, my role provides oversight for effective day-to-day operations of key business offerings including ProPharma Group’s Center of Excellence in Cell and Gene Therapy. I also oversee Project Management, Process Improvement, Technology Transfers, and Process Validation work.

My role is to make sure that our clients’ specific needs are quickly and effectively addressed. One way I accomplish this is to ensure that we have highly skilled staff matched with clients, covering our lifecycle services across many regions. Typically, I work with clients to identify and establish their unique requirements and work within the ProPharma Group organization to ensure our solution exceeds the clients’ expectations.

What do you like best about working with clients?

This is an amazing time to work in the healthcare industry. We have transformed from treating symptoms to curing diseases. I have had the opportunity to work with incredible people at the National Institutes of Health to develop improved methods to identify molecular diagnostics for patients who do not have any other options. I have been able to work with suppliers to design better systems to deliver treatments making miracles come true for patients. Every day, I meet with the smartest, most dedicated, and talented people who are working towards the goal of giving people their lives back, and I appreciate the opportunity to partner with clients on these ground-breaking therapies.

What are the biggest challenges on the horizon for our industry?

Science, learning, and application of knowledge is moving faster than our bureaucratic ability to evaluate and approve the applications. The evolution is amazing with multiple CAR-T treatments being approved and many more in pipeline for multiple indications, including multiple orphan diseases and underserved population treatments. Other Advanced Therapeutic Medicinal Products (ATMPs) using genetic, stem cell, mRNA therapies will provide great promise but require more understanding than we have ever thought possible.

Tell us a little bit about yourself outside of work.

I have a wife and five children, all of them outstanding in their own way. My children humble me. I continue to be amazed at the wisdom they show in their daily interactions and the incredible knowledge and drive they demonstrate. I’m a retired Olympic weightlifter, sailor and competitive swimmer who fondly remembers the great competitions, my teammates, and the focus it takes to be successful.

Why are you proud to work at ProPharma Group?

I am proud to work at ProPharma Group because of the specialized teams and collaborative environment we have built. We have multiple teams of experts, each guided by top-level leaders who are continually trained and supported by the best subject matter experts in science, engineering, quality, regulatory, medical information, and pharmacovigilance. Across the company, our teams and colleagues integrate with our clients to ensure their goals are achieved and patient safety is protected.